This topic contains a solution. Click here to go to the answer

Author Question: A patient has a BMI of 35, a fasting plasma glucose of 120 mg/dL, elevated triglycerides, and a ... (Read 28 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
A patient has a BMI of 35, a fasting plasma glucose of 120 mg/dL, elevated triglycerides, and a history of myocardial infarction. The primary care NP plans to initiate dietary and lifestyle counseling and should consider prescribing:
 
  a. ephedra.
  b. orlistat (Xenical).
  c. phentermine (Adipex-P).
  d. phentermine and topiramate (Onexa).

Question 2

A primary care NP has prescribed phentermine for a patient who is obese. The patient loses 10 lb in the first month but reports that the drug does not seem to be suppressing appetite as much as before. The NP should:
 
  a. discontinue the phentermine.
  b. increase the dose of phentermine.
  c. continue the phentermine at the same dose.
  d. change to a combination of phentermine and topiramate.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Tabitha_2016

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

D
Patients who take Onexa have shown improvement in blood glucose levels and triglyceride levels, so this combination is a good choice for this patient.

Answer to Question 2

A
Tolerance to the effects of phentermine usually develops within a few weeks of starting therapy. When this occurs, the drug should be discontinued, not increased. Phentermine use is not recommended longer than a few weeks.





 

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

For a complete list of videos, visit our video library